GlaxoSmithKline Names Emma Walmsley as New Chief Executive
September 20 2016 - 3:09AM
Dow Jones News
By Razak Musah Baba
LONDON-- GlaxoSmithKline PLC on Tuesday named Emma Walmsley as
chief executive officer designate to take over from Andrew Witty
when he retires next year.
In March, the pharmaceutical giant said Mr. Witty would retire
as chief executive in March 2017, after a career at the company
spanning more than 30 years and almost 10 years as its chief
executive.
Ms. Walmsley, who is currently chief executive officer of
GlaxoSmithKline's Consumer Healthcare division, will join the
company's board of directors from January 2017.
Ms. Walmsley joined GlaxoSmithKline in 2010 from L'Oréal.
The company said its remuneration policy is currently under
review and the remuneration committee will begin consultations with
shareholders in the fourth quarter of 2016.
Write to Razak Musah Baba at Razak.Baba@wsj.com
(END) Dow Jones Newswires
September 20, 2016 02:54 ET (06:54 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024